S1663Referred to Committee

Therapeutic Fraud Prevention Act of 2025

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-05-07
Introduced
40
Cosponsors
S
ⓘ
Type

Sponsor

Patty Murray
Patty Murray
Democrat · WA · Senator
Votes with party: 88.8% (839 recorded votes)

Full profile: /officials/M001111

Source: Congress.gov · FEC

Cosponsors (40)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

40 cosponsors on record at Congress.gov. The named list is syncing into Govwatch and will appear here shortly — view on Congress.gov in the meantime.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Read twice and referred to the Committee on Commerce, Science, and Transportation.

2025-05-07

Source: Congress.gov

Committee Activity

Previously

Plain-English Summary

The legislation would establish new federal rules to prevent fraudulent claims about therapeutic treatments and products, giving the government stronger tools to investigate and punish companies that make false health promises to consumers. It would affect manufacturers, sellers, and marketers of health products and treatments, as well as patients who rely on accurate information when making medical decisions. The bill aims to protect people from wasting money on fake cures and potentially dangerous products by cracking down on misleading advertising and unproven claims.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Commerce
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.